Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

APREA THERAPEUTICS, INC.

(APRE)
  Report
Delayed Nasdaq  -  03:59 2022-12-08 pm EST
0.4774 USD   +1.99%
11/17Aprea Therapeutics, Inc. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
11/16Aprea Therapeutics, Inc. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
11/09APREA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Evolution of the average Target Price on APREA THERAPEUTICS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) APREA THERAPEUTICS, INC.
Analyst Recommendations on APREA THERAPEUTICS, INC.
10/10HC Wainwright Assumes Aprea Therapeutics at Buy with $3 Price Target
MT
07/07Wedbush Initiates Aprea Therapeutics With Outperform Rating, $3 Price Target
MT
07/01Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcare, ..
MT
05/25Berenberg Bank Adjusts Aprea Therapeutics' Price Target to $1 From $4, Maintains Hold Rati..
MT
03/16HC Wainwright Adjusts Aprea Therapeutics' Price Target to $2 From $4, Maintains Neutral Ra..
MT
03/16RBC Trims Price Target on Aprea Therapeutics to $4 From $5, Maintains Sector Perform Ratin..
MT
2021Aprea Therapeutics : JPMorgan Downgrades Aprea Therapeutics to Underweight From Neutral
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 0,47 $
Average target price 3,00 $
Spread / Average Target 541%
High Price Target 3,00 $
Spread / Highest target 541%
Low Price Target 3,00 $
Spread / Lowest Target 541%
Consensus detail
Consensus revision (last 18 months)